National Bank of Canada’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
BCIM
ERSOT
JSAM
TRCT
AT
National Bank of Canada's PPH Position: Q1 2026 in Review
National Bank of Canada held its VanEck Pharmaceutical ETF (PPH) position steady in Q1 2026 at 513 shares worth $53.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1959.
National Bank of Canada first reported a position in PPH in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.56M in Q2 2022. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.
- National Bank of Canada held 513 shares of VanEck Pharmaceutical ETF worth $53.5K as of Q1 2026.
- National Bank of Canada left its VanEck Pharmaceutical ETF share count unchanged in Q1 2026.
- VanEck Pharmaceutical ETF made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #1959 holding.
- National Bank of Canada first reported a position in VanEck Pharmaceutical ETF in Q4 2021 and has held it in 18 quarters since.
- National Bank of Canada's VanEck Pharmaceutical ETF position peaked at $1.56M in Q2 2022.
- 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.
Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.